Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells

Blood. 2001 Mar 15;97(6):1835-44. doi: 10.1182/blood.v97.6.1835.

Abstract

Engagement of the plasma membrane receptor Fas can induce apoptosis of leukemic cells. Signaling through Fas requires the formation of a death-inducing signaling complex (DISC) that involves the cytoplasmic domain of Fas, the adaptor molecule FADD/MORT-1, and procaspase-8. The present study investigated whether another caspase, known as procaspase-2L, played a role in Fas-mediated cell death. A series of human leukemic variant cells was derived by stable transfection with a CASP2L antisense construct (CASP2L/AS). Specific down-regulation of procaspase-2L decreased the sensitivity of these cells to apoptosis induced by an agonistic anti-Fas antibody (Ab, clone CH11), as determined by studying DNA fragmentation, chromatin condensation, and externalization of phosphatidylserine on the plasma membrane. In leukemic cells transfected with an empty vector, anti-Fas Ab treatment activated caspase-8, decreased the expression of the BH3 domain-only protein Bid, triggered the release of cytochrome c from the mitochondria to the cytosol, and activated caspase-3. All these events could not be observed when CASP2L/AS cells were similarly treated with anti-Fas Abs. CASP2L/AS transfection did not inhibit the formation of the DISC and no direct interaction between procaspase-2L and either Fas or FADD or procaspase-8 was identified. Down-regulation of procaspase-2L inhibited anti-Fas Ab-mediated cleavage of c-FLIP (FLICE-inhibitory protein), a protein that interferes with the formation of a functional DISC. These results suggest that the long isoform of caspase-2 plays a role in the Fas-mediated pathway to cell death by contributing to caspase-8 activation at the DISC level.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • BH3 Interacting Domain Death Agonist Protein
  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • Carrier Proteins / drug effects
  • Carrier Proteins / metabolism
  • Caspase 2
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Caspases / drug effects
  • Caspases / genetics
  • Caspases / metabolism
  • Caspases / pharmacology
  • Caspases / physiology*
  • Cytochrome c Group / drug effects
  • Cytochrome c Group / metabolism
  • DNA, Antisense / pharmacology
  • Humans
  • Intracellular Signaling Peptides and Proteins*
  • Leukemia / drug therapy*
  • Leukemia / pathology
  • Protein Isoforms / genetics
  • Protein Isoforms / pharmacology
  • Protein Isoforms / physiology
  • Transfection
  • Tumor Cells, Cultured
  • fas Receptor / pharmacology*

Substances

  • BH3 Interacting Domain Death Agonist Protein
  • BID protein, human
  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • CFLAR protein, human
  • Carrier Proteins
  • Cytochrome c Group
  • DNA, Antisense
  • Intracellular Signaling Peptides and Proteins
  • Protein Isoforms
  • fas Receptor
  • CASP3 protein, human
  • CASP8 protein, human
  • CASP9 protein, human
  • Caspase 2
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Caspases